Experts underscore uncertainty about AstraZeneca’s dosage and efficacy
This weekend’s approval of AstraZeneca’s vaccine by the Drugs Controller General of India has stirred some controversy in the public and the scientific community. Apart from the most obvious point – the vaccine, developed by AstraZeneca and Oxford University showed only 62.1 percent efficacy, much lower than other major vaccines already approved for use in …
Experts underscore uncertainty about AstraZeneca’s dosage and efficacy Read More »